Frequency of Developing COVID-19 Pneumonia in Patients Who Were Vaccinated Double-Dose CoronaVac: Data of the Pandemic Authorized Hospital in Northern Cyprus

Abstract

Background: RT-PCR is the leading method used in the diagnosis of COVID-19, caused by 2019-nCoV. CT applications also provide a fast  and easy diagnosis for detecting pneumonia caused by the SARS-CoV-2 virus. The current study, aimed to compare the lung involvement  of vaccinated (two-dose CoronaVac) and unvaccinated patients in the early stage of COVID-19 disease. Methods: In the current  retrospective study, which included patients diagnosed with RT-PCR COVID-19 positivity (n=651) between 01 July 2021-15 September 2021,  patient information was obtained from the authorized hospital of the pandemic. Data included patients' chest CT scans and  whether patients had been vaccinated (two-dose CoronaVac) information. Results: The ratio of vaccination with double-dose CoronaVac in positive patients was 74.3%. The ratio of patients with normal lung appearance was 61.8%. It was determined that the ratio of involvement in both lungs of patients who were vaccinated with a double dose was significantly lower than the ratio of involvement in patients who were never vaccinated (p < 0.001). Conclusion: In this study, it was determined that pneumonia cases were less common in  individuals vaccinated with double-dose CoronaVac. In this study, it was also determined that the protection of the vaccine was higher in  females than in males and that the protection of the double-dose CoronaVac vaccine was higher in the 50-60 age group compared to 60  older patients.